Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Tabletop Fire Pit Lawsuit Individuals who suffered severe burns, or families who lost a loved one in a tabletop fire pit explosion, may be eligible for financial compensation through a fire pit injury lawsuit.
Dupixent Lawsuit Dupixent lawsuits are being investigated for patients who developed rare blood cancers such as cutaneous T-cell lymphoma (CTCL) after receiving injections, alleging that Sanofi and Regeneron failed to warn about the potential risks of immune suppression and delayed cancer diagnosis.
Roblox Lawsuit Families are filing Roblox lawsuits after children were targeted by predators for grooming, sextortion, sexual abuse, or exploitation on the platform. Learn who qualifies, what cases allege, and how to file a confidential claim.
Ocaliva Lawsuit Ocaliva lawsuits are being investigated for users who experienced liver failure, cirrhosis progression, transplant, or death after taking the drug, alleging that Intercept Pharmaceuticals failed to warn about the risk of dosing toxicity and accelerated liver damage.
ByHeart Formula Recall Lawsuit Parents are now filing ByHeart recall lawsuits alleging that contaminated infant formula caused botulism and other serious illnesses after the company failed to prevent or warn about dangerous manufacturing lapses.
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Roundup Safety Standards Should Be Reassessed: Report March 29, 2017 Austin Kirk Add Your Comments A group of researchers from the U.S. and U.K. are calling for a new assessment of the safety risks of glyphosate, the active ingredient in the weedkiller Roundup, which has been linked to an increased risk of non-Hodgkin’s lymphoma and other cancers. An essay was published this month in the medical journal The BMJ warns that the use of glyphosate and glyphosate-based herbicides (GBHs) has increased 100-fold since it was first introduced in 1974, raising serious concerns since safety profiles of the chemical being generated today are still based on studies conducted more than 30 years ago. Researchers note that environmental health science methods have improved vastly over the past 30 years, with the introduction of cutting-edge technology and new methodologies and knowledge about how such substances could affect the environment. ROUNDUP LAWSUITS Were you or a loved one exposed to RoundUp? Exposure to RoundUp has been linked to an increased risk of developing Non-Hodgkin’s Lymphoma and other cancers. RoundUp cancer lawsuits are being actively investigated. Learn More SEE IF YOU QUALIFY FOR COMPENSATION ROUNDUP LAWSUITS Were you or a loved one exposed to RoundUp? Exposure to RoundUp has been linked to an increased risk of developing Non-Hodgkin’s Lymphoma and other cancers. RoundUp cancer lawsuits are being actively investigated. Learn More SEE IF YOU QUALIFY FOR COMPENSATION “Human exposures to glyphosate are rising, and a number of in vitro and in vivo studies challenge the basis for the current safety assessment of glyphosate and GBHs,” the researchers note. “We conclude that current safety standards for GBHs are outdated and may fail to protect public health or the environment.” The essay calls for three major improvements that could help better define glyphosate safety risks, including monitoring humans for glyphosate and its metabolites; making glyphosate and GBH hazard assessments a priority that includes state-of-the-art toxicology studies; conducting epidemiological studies with a focus on agricultural workers who undergo regular Roundup exposure, as well as pregnant women and children; and evaluating what effects commercially used formulations have on glyphosate, in addition to studies on the effects of glyphosate alone. The concerns come as Monsanto faces a growing number of Roundup lawsuits filed by farmers, landscapers and other agricultural workers diagnosed with non-Hodgkin’s lymphoma or other forms of cancer following regular and consistent exposure to the glyphosate-based weedkiller, alleging that the manufacturer knew or should have known about the risk, yet withheld important warnings and safety precautions from consumers. The litigation has emerged since information about the link between Roundup and non-Hodgkin’s lymphoma became more widely known, following a warning issued by the World Health Organization’s International Agency for Research on Cancer (IARC) in March 2015, which classified glyphosate as a probable human carcinogen. A recent U.S. Geological Survey on glyphosate usage nationwide found that an estimated 2.6 billion pounds of the herbicide has been sprayed on America’s agricultural land over the two decades since the mid-1990s, when Monsanto introduced “Roundup Ready” crops that are designed to survive being sprayed with glyphosate, killing the weeds but not the crops. Tags: Cancer, Glyphosate, Herbicide, Monsanto, Non-Hodgkins Lymphoma, Roundup, Weed Killer More Roundup Lawsuit Stories Roundup Safety Study Retracted Decades After Publication December 8, 2025 Monsanto Roundup Settlement Avoids $2B Payout in Non-Hodgkin’s Lymphoma Lawsuit November 18, 2025 Bayer’s Roundup Lawsuit Payouts Result in Another $1.37B in Reserves August 4, 2025 0 Comments EmailThis field is for validation purposes and should be left unchanged.Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA Term Δ MORE TOP STORIES Class Action Lawsuit Against FanDuel Seeks To Recover Losses for Californians (Posted: yesterday) A lawsuit against FanDuel claims the company is operating illegal fantasy sports betting in California, which has an active ban against online gambling. MORE ABOUT: SPORTS BETTING ADDICTION LAWSUITLawsuit Over DraftKings ‘No Risk’ Bet Promotions Cleared to Move Forward (11/25/2025)Lawsuit Over FanDuel, DraftKings Sports Betting Problems Returned to State Court (11/20/2025)Sports Betting Corruption and Addiction Concerns Highlighted By Recent MLB, NBA Player Indictments (11/12/2025) Court To Weigh Evidence That Depo-Provera Causes Meningioma Tumors in Mid-2026 (Posted: 2 days ago) A federal judge is expected to decide which scientific experts each side may present during the early Depo-Provera meningioma test trials around the middle of next year. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Lawsuit MDL Status Hearings Scheduled Throughout 2026 (12/01/2025)Depo-Provera Litigation Now Includes Over 2,000 Brain Tumor Lawsuits Brought by Women (11/20/2025)Lawsuit Alleges Depo-Provera Caused Brain Surgery, After Meningioma Diagnosis (11/11/2025) Dupixent CTCL Lawsuit Filed Over Diagnosis of Both Mycosis Fungoides and Sezary Syndrome (Posted: 5 days ago) A Louisiana man was diagnosed with two rare forms of T-cell lymphoma after receiving Dupixent injections for less than two years. MORE ABOUT: DUPIXENT LAWSUITDrug Makers Must Respond to Dupixent Lawsuit Over Lymphoma Diagnosis by Jan. 7, 2026 (12/02/2025)Dupixent for Nasal Polyps Nears FDA Approval Amid Lymphoma Side Effect Lawsuits (11/17/2025)Dupixent Sales Surge Amid Growing CTCL Cancer Lawsuit Allegations (10/29/2025)
Class Action Lawsuit Against FanDuel Seeks To Recover Losses for Californians (Posted: yesterday) A lawsuit against FanDuel claims the company is operating illegal fantasy sports betting in California, which has an active ban against online gambling. MORE ABOUT: SPORTS BETTING ADDICTION LAWSUITLawsuit Over DraftKings ‘No Risk’ Bet Promotions Cleared to Move Forward (11/25/2025)Lawsuit Over FanDuel, DraftKings Sports Betting Problems Returned to State Court (11/20/2025)Sports Betting Corruption and Addiction Concerns Highlighted By Recent MLB, NBA Player Indictments (11/12/2025)
Court To Weigh Evidence That Depo-Provera Causes Meningioma Tumors in Mid-2026 (Posted: 2 days ago) A federal judge is expected to decide which scientific experts each side may present during the early Depo-Provera meningioma test trials around the middle of next year. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Lawsuit MDL Status Hearings Scheduled Throughout 2026 (12/01/2025)Depo-Provera Litigation Now Includes Over 2,000 Brain Tumor Lawsuits Brought by Women (11/20/2025)Lawsuit Alleges Depo-Provera Caused Brain Surgery, After Meningioma Diagnosis (11/11/2025)
Dupixent CTCL Lawsuit Filed Over Diagnosis of Both Mycosis Fungoides and Sezary Syndrome (Posted: 5 days ago) A Louisiana man was diagnosed with two rare forms of T-cell lymphoma after receiving Dupixent injections for less than two years. MORE ABOUT: DUPIXENT LAWSUITDrug Makers Must Respond to Dupixent Lawsuit Over Lymphoma Diagnosis by Jan. 7, 2026 (12/02/2025)Dupixent for Nasal Polyps Nears FDA Approval Amid Lymphoma Side Effect Lawsuits (11/17/2025)Dupixent Sales Surge Amid Growing CTCL Cancer Lawsuit Allegations (10/29/2025)